Hubungan Kadar Ubiqutin C-Terminal Hydrolase – L1 Dengan Tingkat Keparahan Cedera Kepala

DAFTAR PUSTAKA

  Adalbert R., Nógrádi A., Szabó A., Coleman M.P. (2006) The slow Wallerian degeneration gene in vivo protects motor axons but not their cell bodies Eur J Neurosci 24:2163–2168 after avulsion and neonatal axotomy.

  American Academy of Neurology (1995) Determining brain death in Neurology 45:1012- 1014. adult. Anderson J.P (2006) Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. J Biol Chem281: 29739- 52 Essays Biochem41:15-30. Ardley H.C., Robinson P.A. (2005) E3 ubiquitin ligases. Babetto E., Beirowski B., Janeckova L., Brown R., Gilley J., Thomson D.,

  Ribchester R.R., Coleman M.P. (2010) Targeting NMNAT1 to axons and synapses transforms its neuroprotective potency invivo. J Neurosci 30:13291-13304

  Baker R.T., Board P.G. (1987) The human ubiquitin gene family: structure of a Nucleic Acids Res15: gene and pseudogenes from the Ub B subfamily. 443-63. Beirowski B., Adalbert R., Wagner D., Grumme D.S., Addicks K., Ribchester R.R.,

  Coleman M.P. (2005) The progressive nature of Wallerian degeneration in BMC Neurosci wild-type and slow Wallerian degeneration (WldS) nerves. 6:6

  Berger F., Lau C., Dahlmann M., Ziegler M. (2005) Subcellular compart- mentation and differential catalytic properties of the three human nicotinamide mononucleotide adenylyltransferase isoforms. J Biol Chem 280:36334–36341

  Berger R.P., Pierce M.C., Wisniewski S.R., Adelson P.D., Clark R.S., Ruppel R.A., Kochanek P.M. (2002) Neuron- specific enolase and S100B in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatrics 109:E31. Bendlin B.B., Ries M.L., Lazar M., Alexander A.L., Dempsey R.J., Rowley H.A.,

  Sherman J.E., Johnson S.C. (2008) Longitudinal changes in patients with traumatic brain injury assessed with diffusion-tensor and volumetric imaging. Neuroimage, 42: 503-514. Bener A., Omar A.O., Ahmad E., Al-Mulla F.H., Abdul Rahman Y.S. (2010) The pattern of traumatic brain injuries: a country undergoing rapid

  Brain Inj 24:74-80 development. Berger R.P., Beers S.R., Richichi R., Wiesman D., Adelson P.D. (2007) Serum biomarker concentrations and outcome after pediatric traumatic brain injury. J Neurotrauma 24: 1793-1801. Bigler E.D., Maxwell W.L. (2011) Neuroimaging and neuropathology of NeuroRehabilitation 28: 63-74.

  TBI. Blyth B.J., Farahvar A., He H., Nayak A., Yang C., Shaw G. (2011) Elevated

  Serum Ubiquitin Carboxy-Terminal Hydrolase L1 is Associated with Abnormal Blood Brain-Barrier Function after Traumatic Brain Injury. J of Neurotr 28:2453-2462.

  Cardozo T., Pagano M. (2004) The SCF ubiquitin ligase: insights into a molecular machine. Nat Rev Mol Cell Biol5(9): 739-51. Case A, Stein R.L. (2006) Mechanistic studies of ubiquitin C-terminal hydrolase L1. Biochemistry45(7): 2443-52.

  Clark R.S., Bayir H., Chu C.T., Alber S.M., Kochanek P.M., Watkins S.C. (2008) Autophagy is increased in mice after traumatic brain injury and is detectable in human brain after trauma and critical illness. Autophagy 4: 88-90. Conforti L., Wilbrey A., Morreale G., Janeckova L., Beirowski B., Adalbert R.,

  Mazzola F., Di Stefano M., Hartley R., Babetto E., Smith T., Gilley J., Billington R.A., Genazzani A.A., Ribchester R.R., Magni G., Coleman M. (2009) Wld S protein requires Nmnat activity and a short N-terminal sequence to protect axons in mice. J Cell Biol 184:491–500

  Dahlmann B. (2007) Role of proteasomes in disease. BMC Biochem8 (Suppl 1): S3. Daniel J.A., Grant P.A. (2007) Multi-tasking on chromatin with the SAGA

  Mutat Res618 :135-48 coactivator complexes. Dash P.K., Zhao J., Hergenroeder G., Moore A.N. (2010) Biomarker for the diagnosis, prognosis, and evaluation of treatment efficacy for traumatic brain injury. Neurotherapeutics 7:100-114. Decressac M., Ulusoy A., Mattsson B., Georgievska B., Romero-Ramos M., Kirik

  D., Björklund A. (2011) GDNF fails to exert neuropro- tection in a rat Brain 134:2302–2311 {alpha}-synuclein model of Parkinson’s disease. Deng P.Y., Lei S. (2007) Long-term depression in identified stellate neurons of juvenile rat entorhinal cortex. J Neurophysiol97: 727-37.

  Donat C.K., Schuhmann M.U., Voigt C., Nieber K., Deuther-Conrad W., Brust P.

  (2008) Time-dependent alterations of cholinergic markers after experimental traumatic brain injury. Brain Res 1246: 167-177.

Donato R. (1999) Function roles of S100β proteins, calcium binding proteins of the EF-hand type. Biochim Biophys Acta 1450:234-241

  Falzone T.L., Stokin G.B., Lillo C., Rodrigues E.M., Westerman E.L., Williams D.S., Goldstein L.S.B. (2009) Axonal stress kinase activa- tion and tau

  J Neurosci 29:5758– misbehavior induced by kinesin-1 transport defects. 5767

  Faul M., Xu L., Wald M.M., Coronado V.G. (2010) Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations and Deaths

  Centers for Disease Control and Prevention, 2002–2006. Atlanta (GA): National Center for Injury Prevention and Control.

  Finkelstein E., Corso P., Miller T. and Associates. (2006) The Incidence and Economic Burden of Injuries in the United States. New York (NY): Oxford University Press.

  George E.B., Glass J.D., Griffin J.W. (1995) Axotomy-induced axonal J Neurosci 75:6445– degeneration influx through ion-specific channels. 6452

  Gilley J., Coleman M.P. (2010) Endogenous Nmnat2 is an essential survival factor PLoS Biol 8: e1000300 for maintenance of healthy axons. Gong B. (2006) Ubiquitin hydrolase Uch-L1 rescues beta-amyloid- induced decreases in synaptic function and contextual memory. Cell 126: 775-88.

  Gong B., Leznik E. (2007) The role of ubiquitin C-terminal hydrolase L1 in neurodegenerative disorders. Drug News Perspect 20:365-370.

  Goodacre S. (2008) Hospital admissions with head injury following publication of Emerg Med J 25:556-557.

  NICE guidance.

  th Greenberg M.S., ed (2010) Handbook of neurosurgery, 7 ed. New York: Thieme.

  Hafezparast M. (2003) Mutations in dynein link motor neuron degen- eration to defects in retrograde transport. Science 300:808–812 Hegde A.N. (2004) Ubiquitin-proteasome-mediated local protein degradation and Prog Neurobiol73: 311-57. synaptic plasticity. Hatakeyama S., Yada M., Matsumoto M., Ishida N., Nakayama K.I. (2001) U box proteins as a new family of ubiquitin-protein ligases. J Biol Chem

  276:33111–33120 Hu B.R., Liu C.L., Ouyang Y., Blomgren K., Siesjo B.K. (2000) Involvement of caspase-3 in cell death after hypoxia-ischemia declines during brain maturation. J Cereb Blood Flow Metab 20:1294-1300. Hyder A.A., Wunderlich C.A., Puvanachandra P., Gururaj G., Kobusingye O.C.

  (2007) The impact of traumatic brain injuries: a global perspective. NeuroRehabilitation 22:341-353

  Jackson P., Thompson R.J. (1981) The demonstration of new human brain-specific proteins by high-resolution-two dimensional polyacrylamide gel electrophoresis. J Neurol Sci 49:429-438. Kahle P.J. (2000) Subcellular localization of wild-type and Parkinson's disease- associated mutant alpha -synuclein in human and transgenic mouse brain.

  J Neurosci20: p. 6365-73. Kanazawa T., Uchihara T., Takahashi A., Nakamura A., Orimo S., Mizusawa H.

  (2008) Three-layered structure shared between Lewy bodies and Lewy neurites—three-dimensional reconstruction of triple-labeled sections. Brain Pathol 18:415–422

  Keller J.N., Huang F.F., Zhu H., Yu J., Ho Y.S., Kindy T.S. (2000) Oxidative stress-associated impairment of proteasome activity during ischemia- reperfusion injury. J Cereb Blood Flow Metab20 :1467-1473. Kelley B.J., Farkas O., Lifshitz J., Povlishock J.T. (2006) Traumatic axonal injury in the perisomatic domain triggers ultrarapid secondary axotomy and

  Exp Neurol 198: 350-360. Wallerian degeneration.

  Kennedy R.D., D'Andrea A.D. (2005), The Fanconi Anemia/BRCA pathway: new faces in the crowd. Genes Dev.19: 2925- 40. Kerschensteiner M., Schwab M.E., Lichtman J.W., Misgeld T. (2005) In vivo imaging of axonal degeneration and regeneration in the injured spinal

  Nat Med 11:572–577 cord. Kilinc D., Gallo G., Barbee K. (2009) Mechanical membrane injury induces axonal beading through localized activation of calpain. Exp Neurol 219:553–561 Knöferle J., Koch J.C., Ostendorf T., Michel U., Planchamp V., Vutova P., Tönges

  L., Stadelmann C., Brück W., Bähr M., Lingor P. (2010) Mechanisms of Proc Natl Acad Sci acute axonal degeneration in the optic nerve in vivo. USA 107:6064–6069

  Kobeissy F.H., Ottens A.K., Zhang Z., et. al. (2006) Novel differential neuroproteomic analysis of traumatic brain injury in rats. Mol Cell Proteomics 5:1887-1898.

  Kobeissy F.H., Sadasivan S., Oli M.W., Robinson G., Larner S.F., Zhang Z., Hayes R.L., Wang K.K. (2008) Neuroproteomics and systems biology-based discovery of protein biomarkers for traumatic brain injury and clinical validation. Proteomics Clin Appl2:1467–1483

  Kobori N., Hu B., Dash P.K. (2011) Altered adrenergic receptor signaling following traumatic brain injury contributes to working memory Neuroscience 172: 293-302. dysfunction. Koch J.C., Knöferle J., Tönges L., Ostendorf T., Bähr M., Lingor P. (2010) Acute axonal degeneration in vivo is attenuated by inhibition of autophagy in a calcium-dependent manner. Autophagy (in press) Kochanek P.M., Berger R.P., Bayir H., Wagner A.K., Jenkins L.W., Clark R.S. (2008) Biomarker of primary and evolving damage in traumatic and ischemic brain injury: diagnosis, prognosis, probing mechanism, and therapeutic decision maker. Curr Opin Crit Care 43:267-270. Koegl M. (1999) A novel ubiquitination factor, E4, is involved in multiubiquitin Cell96: 635-44. chain assembly. Komada M. (2008) Controlling receptor downregulation by ubiquitination and Curr Drug Discov Technol5 : 78-84. deubiquitination. Kuo C.T. (2006) Identification of E2/E3 ubiquitinating enzymes and caspase activity regulating Drosophila sensory neuron dendrite pruning.Neuron 51:

  283-90. Larsen C.N., Krantz B.A., Wilkinson K.D. (1998) Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases.

  Biochemistry37: 3358-68. Leroy E. (1998) The ubiquitin pathway in Parkinson's disease. Nature 395: 451-2. Levy M.L., Ozgur B.M., Berry C., Aryan H.E., Apuzzo M.L. (2004) Birth and Neurosurgery 55:656-661. evolution of the football helmet. Lin J.W., Lin C.M., Tsai J.T., Hung K.S., Hung C.C., Chiu W.T. (2008) Neurotrauma research in Taiwan. Acta Neurochir Suppl 101:113-117.

  Lincoln S., Vaughan J., Wood N., et. al. (1999) Low frequency of pathogenic mutations in the ubiquitin carboxy-terminal hydrolase gene in familial Neuroreport 10:427-429. Parkinson’s disease. Lingor P.,Koch J.C., Tönges L., Bähr M. (2012) Axonal degeneration as a

  Cell Tissue Res

  therapeutic target in the CNS. 349:289–311 Liu Y. (2002) The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility.

  Cell111: 209-18. Lunn E.R., Perry V.H., Brown M.C., Rosen H., Gordon S. (1989) Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve.

  Eur J Neurosci 1:27–33 Lwangsa S.K., Lemeshow. (1998) Sample size determination in health studies, a World Health Organization. practical manual version 2.00. Lyeth B.G., Hayes R.L. (1992) Cholinergic and opioid mediation of traumatic brain J Neurotrauma 9 (Suppl 2): S463-474.. injury. MacDonald J.M., Beach M.G., Porpiglia E., Sheehan A.E., Watts R.J., Freeman M.R. (2006) The Drosophila cell corpse engulfment receptor Draper mediates glial clearance of severed axons. Neuron 50:869–881

  Malinow R. (2003) AMPA receptor trafficking and long-term pot entiation.Philos Trans R Soc Lond B Biol Sci358: 707-14. McIntosh T.K., Smith D.H., Meaney D.F., Kotapka M.J., Gennarelli T.A., Graham

  D.I. (1996) Neuropathological sequelae of traumatic brain injury: Lab relationship to neurochemical and biomechanical mecha- nisms. Invest 74:315–342 Menon D.K. (2009) Unique challenges in clinical trials in traumatic brain injury.

  Crit Care Med 37:S129-135. Meythaler J.M., Peduzzi J.D., Eleftheriou E., Novack T.A. (2001) Current concepts: diffuse axonal injury-associated traumatic brain injury. Arch

  Phys Med Rehabil 82:1461–1471 Mondello S., Linnet A., Buki A., et. al. (2012) Clinical Utility of Serum Levels of

  Ubiquitin C-Terminal Hydrolase as a Biomarker for Severe Traumatic Neurosurgery 70:666-675. Brain Injury. Morfini G.A., Burns M., Binder L.I., Kanaan N.M., LaPointe N., Bosco D.A.,

  Brown R.H., Brown H., Tiwari A., Hayward L., Edgar J., Nave K-A., Garberrn J., Atagi Y., Song Y., Pigino G., Brady S.T. (2009) Axonal

  J Neuro- sci 29:12776– transport defects in neurodegenerative diseases. 12786

  Nath S., Goodwin J., Engelborghs Y., Pountney D.L. (2011) Raised calcium promotes α-synuclein aggregate formation. Mol Cell Neurosci 46:516–526 Nijman S.M. (2005) A genomic and functional inventory of deubiquitinating Cell 123: 773-86. enzymes.

Nikić I ., Merkler D., Sorbara C., Brinkoetter M., Kreutzfeldt M., Bareyre F.M.

  Brück W., Bishop D., Misgeld T., Kerschensteiner M. (2011) A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med 17:495–499

  Nikolaeva M.A., Mukherjee B., Stys P.K. (2005) Na+-dependent sources of intra- axonal Ca2+ release in rat optic nerve during in vitro chemical ischemia.

  J Neurosci 25:9960–9967 Nirula R., Mock C.N., Nathens A.B., Grossman D.C. (2004) The new car assessment program: does it predict the reality safety of vehicles in actual

  J Trauma 57:779-786. crashes?

  Osaka H. (2003) Ubiquitin carboxy-terminal hydrolase L1 binds to and stabilizes monoubiquitin in neuron. Hum Mol Genet 12: 1945-58. Ouardouz M., Nikolaeva Ma., Coderre E., Zamponi G.W., McRory J.E., Trapp

  B.D., Yin X., Wang W., Woulfe J., Stys P.K. (2003) Depolarization- induced Ca2+ release in ischemic spinal cord white matter involves L-type Neuron 40:53–63 Ca2+ channel activation of ryano- dine receptors. Papa L., Akinyi L., Liu M.C., Pineda J.A., et. al. (2010) Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe head injury. Crit Care

  Med 38:138-144. Pelinka L.E., Kroepfl A., Leixnering M., Buchinger W., Raabe A., Redl H. (2004)

GFAP versus S100β in serum after traumatic brain injury: relationship to brain damage and outcome. J Neurotrauma 24: 1793-1801

  Pettus E.H., Christman C.W., Giebel M.L., Povlishock J.T. (1994) Trau- matically induced altered membrane permeability: its relationship to traumatically J Neurotrauma 11:507–522 induced reactive axonal change. Pettus E.H., Povlishock J.T. (1996) Characterization of a distinct set of intra- axonal ultrastructural changes associated with traumatically induced alteration in axolemmal permeability. Brain Res 722:1–11 Pickart C.M. (2004) Back to the future with ubiquitin. Cell116:181-90. Pickart C.M., Rose I.A. (1985) Ubiquitin carboxyl-terminal hydrolase acts on J Biol Chem260 :7903-10. ubiquitin carboxyl-terminal amides. Piotrowski J. (1997) Inhibition of the 26 S proteasome by polyubiquitin chains synthesized to have defined lengths. J Biol Chem272: 23712-21. Raff M.C., Whitmore A.V., Finn J.T. (2002) Axonal self-destruction and

  Science 296:868–871 neurodegeneration. Ravikumar B., Acevedo-Arozena A., Imarisio S., Berger Z., Vacher C., O’Kane

  C.J., Brown S.D.M., Rubinsztein D.C. (2005) Dynein muta- tions impair autophagic clearance of aggregate-prone proteins. Nat Genet 37:771–776 Reilly P. (2007) The impact of neurotrauma on society: an international Prog Brain Res 161:3-9. perspective.

  Neurol Res 21:330- Reinert M.M., Bullock R. (1999) Clinical trials in head injury. 338

  Robicsek G.M., Gabrielli S.A., Robertson C.S., Wang K.K., and Hayes R.L. (2008) Use of biomarkers for diagnosis and management of traumatic brain Expert Opin. Med Diagn 28: 1–9. injury. Ross C.A., Poirier M.A. (2004) Protein aggregation and neurodegenerative disease.

  Nat Med10 (Suppl): S10-7. Ross S.A., Cunningham R.T., Johnston C.F., Rowlands B.J. (1996) Neuron specific enolase as an aid to outcome prediction in head injury. Br J Neurosurg

  10:471-476 Rubinsztein D.C. (2006) The roles of intracellular protein-degradation pathways in neurodegeneration. Nature443: 780-6.

  Sasaki Y., Vohra B.P.S., Lund F.E., Milbrandt J. (2009b) Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide

  J Neurosci 29:5525–5535 adenine dinucleotide. Saatman K.E., Creed J., Raghupathi R. (2010) Calpain as a therapeutic target in traumatic brain injury. Neurotherapeutics 7:31–42 Schmidt M, et. al. (2005) Proteasome-associated proteins: regulation of a Biol Chem386: 725-37. proteolytic machine. Setsuie R. (2007) Dopaminergic neuronal loss in transgenic mice expressing the

  Parkinson's disease-associated UCH-L1 I93M mutant. Neurochem Int 50: p. 119-29. Shimura H. (2000) Familial Parkinson disease gene product, parkin, is 
 a Nat Genet25: 302-5. ubiquitin-protein ligase. Sidaros A., Skimminge A., Liptrot M.G., Sidaros K., Engberg A.W., Herning M., Paulson O.B., Jernigan T.L., Rostrup E. (2009) Long-term global and regional brain volume changes following severe traumatic brain injury: a longitudinal study with clinical correlates. Neuroimage 44: 1-8. Siebert H., Kahle P.J., Kramer M.L., Isik T., Schlüter O.M., Schulz- Schaeffer

  W.J., Brück W. (2010) Over-expression of alpha- synuclein in the nervous system enhances axonal degeneration after peripheral nerve lesion in a J Neuro- chem 114:1007–1018 transgenic mouse strain. Sievers C., Platt N., Perry V.H., Coleman M.P., Conforti L. (2003) Neurites undergoing Wallerian degeneration show an apoptotic-like pro- cess with annexin V positive staining and loss of mitochondrial membrane potential. Neurosci Res 46:161–169

  Song L., Rape M. (2008) Reverse the curse--the role of deubiquitination in cell cycle control. Curr Opin Cell Biol20 :156-63. Staal J.A., Dickson T.C., Gasperini R., Liu Y., Foa L., Vickers J.C. (2010) Initial calcium release from intracellular stores followed by calcium dysregulation is linked to secondary axotomy following transient axonal

  J Neurochem 112:1147–1155 stretch injury. Stirling D.P., Stys P.K. (2010) Mechanisms of axonal injury: internodal nanocomplexes and calcium deregulation. Trends Mol Med 16:160–170 Tang-Schomer M.D., Patel A.R., Baas P.W., Smith D.H. (2010) Mechanical breaking of microtubules in axons during dynamic stretch injury underlies delayed elasticity, microtubule disassembly, and axon degeneration. FASEB J 24:1401–1410

  Teasdale G., Jennet B. (1974) Assessment of coma and impaired consciousness : A practical scale. Lancet 2: 81-84 Thurman D.J., Alverson C., Dunn K.A., Guerrero J., Sniezek J.E. (1999) Traumatic

  J Head brain injury in the United States: A public health persective. Trauma Rehabil 14:602-615. Tongaonkar P., Chen L., Lambertson D., Ko B., Madura K. (2000) Evidence for an interaction between ubiquitin-conjugating enzymes and the 26S

  Mol Cell Biol. 20:4691-4698. proteasome.

  Touma E., Kato S., Fukui K., Koike T. (2007) Calpain-mediated cleavage of collapsin response mediator protein (CRMP)-2 during neurite degeneration in mice. Eur J Neurosci 26:3368–3381

  Trivedi M.A., Ward M.A., Hess T.M., Gale S.D., Dempsey R.J., Rowley H.A., Johnson S.C. (2007) Longitudinal changes in global brain volume between 79 and 409 days after traumatic brain injury: relationship with duration of coma. J Neurotrauma 24: 766- 771. Upadhya S.C., Hegde. (2005), Ubiquitin-proteasome pathway components as Curr Pharm Des11: 3807-28. therapeutic targets for CNS maladies. Utton M.A., Noble W.J., Hill J.E., Anderton B.H., Hanger D.P. (2005) Molecular motors implicated in the axonal transport of tau and alpha-synuclein. J

  Cell Sci 118:4645–4654 Van Roessel P. (2004) Independent regulation of synaptic size and activity by the Cell119: 707-18. anaphase-promoting complex. Veeranna A., Kaji T., Boland B., Odrljin T., Mohan P., Basavarajappa B.S., Peterhoff C., Cataldo A., Rudnicki A., Amin N., Li B.S., Pant H.C., Hungund B.L., Arancio O., Nixon R.A. (2004) Calpain mediates calcium- induced activation of the erk1,2 MAPK pathway and cytoskeletal phosphorylation in neurons: relevance to Alzheimer’s disease. Am J Pathol 165:795–805

  Von Coelln R. (2004) Loss of locus coeruleus neurons and reduced startle in parkin Proc Natl Acad Sci U S A101: 10744-9. null mice. Vosler P.S., Brennan C.S., Chen J. (2008) Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration. Mol Neu- robiol 38:78–100 Wang K.K., Ottens A.K., Lie M.C., et. al. (2005) Proteomic identification of Expert Rev Proteomics 2:603-604. biomarker of traumatic brain injury. Weston C.R., Davis R.J. (2007) The JNK signal transduction pathway. Curr Opin

  Cell Biol 19:142–149 Whitmore A.V., Lindsten T., Raff M.C., Thompson C.B. (2003) The proa-poptotic

  Cell proteins Bax and Bak are not involved in Wallerian degeneration. Death Differ 10:260–261

  Wilkinson K.D. (1989) The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase. Science246: 670-3. Yahata N., Yuasa S., Araki T. (2009) Nicotinamide mononucleotide adenylyltransferase expression in mitochondrial matrix delays Wallerian

  J Neurosci 29:6276–6284 degeneration. Yamazaki Y., Yada K., Morii S., Kitahara T., Ohwada T. (1995) Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injury. Surg Neurol 43:267-270. Yao T., Cohen R.E. (2002) A cryptic protease couples deubiquitination and Nature 419:403-7. degradation by the proteasome. Yoshimura K., Ueno M., Lee S., Nakamura Y., Sato A., Yoshimura K., Kishima

  H., Yoshimine T., Yamashimta T. (2011) C-Jun N-terminal kinase induces axonal degeneration and limits motor recovery after spinal cord injury in Neurosci Res 71:266–277 mice. Zetterberg M., Sjolander A., von Otter M., Palmer M.S., Landgren S., Minthon L., et. al. (2010). Ubiquitin carboxy-terminal hydrolase L1 (UCHL1) S18Y polymorphism in Alzheimer’s disease. Molecular Neurodegeneration5:11

  Zhai Q., Wang J., Kim A., Liu Q., Watts R., Hoopfer E., Mitchison T., Luo L., He Z. (2003) Involvement of the ubiquitin-proteasome system in the early

  Neuron 39:217–225 stages of Wallerian degeneration. Zhang L., Yang K.H., King A.I. (2004) A proposed injury threshold for mild traumatic brain injury. J Biomech Eng 126: 226-236.

  Zhao C., Takita J., Tanaka Y., Setou M., Nakagawa T., Takeda S., Yang H.W., Terada S., Nakata T., Takei Y., Saito M., Tsuji S., Hayashi Y., Hirokawa N. (2001) Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 105:587–597

  Zhou H., Chen L., Gao X., Luo B., Chen J. (2012) Moderate traumatic brain injury triggers rapid necrotic death of immature neurons in the hippocampus.

  J Neuropathol Exp Neurol 71: 348-359. Ziebell J.M., Morganti-Kossmann M.C. (2010) Involvement of pro- and anti- inflammatory cytokines and chemokines in the pathophysiology of traumatic brain injury. Neurotherapeutics 7: 22-30

  Ziv N.E., Spira M.E. (1995) Axotomy induces a transient and localized elevation of the free intracellular calcium concentration to the millimolar range.

  J Neurophysiol 74:2625–2637